Circulating Tumour Cells in Patients With Peritoneal Metastases

Uppsala University

Status: Completed

Conditions: Hyperthermic Intraperitoneal Chemotherapy; Circulating Tumor Cell; Peritoneal Metastases

Treatments: Diagnostic Test: iCellate

Study type: Observational

Funder types: Other

Identifiers

NCT04083547

CTC study

Details and patient eligibility

About

This study aims to evaluate the prognostic value of circulating tumour cells (CTC) in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy due to gastrointestinal cancers that have spread to the peritoneum.

Full description

CTCs har extracted by way of a new method at baseline, during surgery, and postoperatively. The occurence of such CTCs will be investigated for prognostic evaluation. Patients will be follow-up by Clinical routine. Disease recurrence and overall survival will be the endpoint used.

Enrollment: 114 patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Peritoneal metastases being treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

Exclusion criteria

• None

Trial design

114 participants in 1 patient group

HIPEC group

Description:

All patients undergoing HIPEC will asked to join this prospective study.

Treatment:

Diagnostic Test: iCellate